Dose adjustment: In clinical trial settings, dose reduction or a temporary dose pause has been used when gastrointestinal side effects become intolerable, allowing the gut to recover before re-escalating more gradually
Lilly said it plans to seek approval from the U.S
The medication carries a risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
I followed her to Thrive from her old med spa (thats now amazing she is!) I see her regularly for Botox and injectables and I am thrilled with my results every time
Hisadome, K., Reimann, F., Gribble, F
Retatrutide is currently in clinical development and is not approved for commercial use